Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Rank in Stocks #40615
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Share Price
$0.13607016
Last synced: 2024-09-10
Market Cap
$112.29K
Change (1 day)
22.46%
Change (1 year)
0.00%
Country
GB
Trade BiVictriX Therapeutics Plc (BVX)

Category

Price of BVX with the market cap of B
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
BVX
$0.13607016
Market Capitalization of BiVictriX Therapeutics Plc(BVX)
Market Cap: $112.29K
As of August 2026 BiVictriX Therapeutics Plc has a market cap of $112.29K. This makes BiVictriX Therapeutics Plc the world's 40615th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of BiVictriX Therapeutics Plc from 2021 to 2026
BVX compared with Top 5 Most Popular stocks
Price of BVX Asset B Mkt. of B Results
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$6,620,661 $112.29K
$5.464T +4,865,622,912.92%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$5,399,500 $112.29K
$4.456T +3,968,173,637.66%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$5,058,556 $112.29K
$4.175T +3,717,608,716.22%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$4,441,504 $112.29K
$3.665T +3,264,127,780.83%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$3,455,913 $112.29K
$2.852T +2,539,801,968.96%